‘Considering the benefit and the risk, we think this preparation totally unsuitable for the treatment of depression.’ — May 25th 1984 communication to Lilly US from Lilly Bad Homburg by B v.Keitz containing a translation of an unofficially received medical comment on the Fluoxetine application to the German regulators. Let Them Eat Prozac
Dr. John Rengen Virapen worked 35 years for Eli Lilly & Co as an executive. He now speaks out on the many crimes “Big Pharma” was and is responsible for and he himself also participated in. Unfortunately, many of its crimes go passed public awareness as it enjoys the unethical protection from its big allies, the mainstream media, the FDA and governments.
Original mixed English-German source, here. More on Dr. Rengen Virapen here (only German).
John Virapen’s website – with contact info and book order instructions:
http://www.side-effects-death.com/
New interview dated 2009-07-27 on blogtalkradio.
http://www.mazaruni-publishing.eu/
Supplemental Material:
- What is iatrogenic disease?
What does the word “iatrogenic” mean?
Iatros means physician in Greek, and -genic, meaning induced by, is derived from the International Scientific Vocabulary. Combined, of course, they become iatrogenic, meaning physician-induced. Iatrogenic disease is obviously, then, disease which is caused by a physician.
Or perhaps it is not so obvious. The growing complexity of modern life (and medicine) has promoted the elasticity of language. In common usage, then, iatrogenic disease is now applied to any adverse effect associated with any medical practitioner or treatment. The practitioner need not be a physician, he might be a nurse or a radiology technician, or any one of the scores of differentiated healthcare workers encountered in hospitals, clinics, nursing homes, or offices, or for that matter in the ambulance on the way to one of those places. Source
- Excerpts from Gary Null’s Death by Medicine, on the unnecessary medical interventions taking place in the US:
As shown in the following table, the estimated total number of iatrogenic deaths—that is, deaths induced inadvertently by a physician or surgeon or by medical treatment or diagnostic procedures— in the US annually is 783,936. It is evident that the American medical system is itself the leading cause of death and injury in the US . By comparison, approximately 699,697 Americans died of heart in 2001, while 553,251 died of cancer.(5)
Using Leape’s 1997 medical and drug error rate of 3 million(14) multiplied by the 14% fatality rate he used in 1994(16) produces an annual death rate of 420,000 for drug errors and medical errors combined. Using this number instead of Lazorou’s 106,000 drug errors and the Institute of Medicine ‘s (IOM) estimated 98,000 annual medical errors would add another 216,000 deaths, for a total of 999,936 deaths annually.
The enumerating of unnecessary medical events is very important in our analysis. Any invasive, unnecessary medical procedure must be considered as part of the larger iatrogenic picture. Unfortunately, cause and effect go unmonitored. The figures on unnecessary events represent people who are thrust into a dangerous health care system. Each of these 16.4 million lives is being affected in ways that could have fatal consequences. Simply entering a hospital could result in the following:
- In 16.4 million people, a 2.1% chance (affecting 186,000) of a serious adverse drug reaction(1)
- In 16.4 million people, a 5-6% chance (affecting 489,500) of acquiring a nosocomial infection(9)
- In16.4 million people, a 4-36% chance (affecting 1.78 million) of having an iatrogenic injury (medical error and adverse drug reactions).(16)
- In 16.4 million people, a 17% chance (affecting 1.3 million) of a procedure error.(40)
These statistics represent a one-year time span. Working with the most conservative figures from our statistics, we project the following 10-year death rates.
Our estimated 10-year total of 7.8 million iatrogenic deaths is more than all the casualties from all the wars fought by the US throughout its entire history.
Our projected figures for unnecessary medical events occurring over a 10-year period also are dramatic.
These figures show that an estimated 164 million people—more than half of the total US population—receive unneeded medical treatment over the course of a decade. Source
-
In their study, Leape and his colleagues examined patient records at hospitals throughout the state of New York. Their 1991 report found that one of every 200 patients admitted to a hospital died as a result of a hospital error.That number of deaths is the equivalent of what would occur if a jumbo jet crashed every day; it is three times the 43,000 people killed each year in U.S. automobile accidents.
“It’s by far the number one problem” in health care, said Leape, an adjunct professor of health policy at the Harvard School of Public Health.
Researchers such as Leape say that not only are medical errors not reported to the public, but those reported to hospital authorities represent roughly 5 to 10 percent of the number of actual medical mistakes at a typical hospital.
“The bottom line is we have a system that is terribly out of control,” said Robert Brook, a professor of medicine at the University of California at Los Angeles.
“It’s really a joke to worry about the occasional plane that goes down when we have thousands of people who are killed in hospitals every year.” Brook’s recognition of the extent of hospital errors is shared by many of medicine’s leaders.
Care — not treatment — is the answer. Drugs, surgery and hospitals become increasingly dangerous for chronic disease cases. Facilitating the God-given healing capacity by improving the diet, exercise, and lifestyle is the key.
Effective interventions for the underlying emotional and spiritual wounding behind most chronic disease is critical for the reinvention of our medical paradigm. These numbers suggest that reinvention of our medical paradigm is called for. Source
- What is FAB?
We promote benefit statements called FAB statements throughout the sales process. What is a FAB statement and how is it organized?
F for Feature – What is the feature
A for Advantage – What does the feature do
B for Benefit – The “What’s in it for me?” for the customer
As you meet with your customers and find out about their priorities and specific requirements, the information they provide you will enable you to use FAB statements to positively influence the sale. What you are doing is making the buying process straightforward for the client. Rather than imposing on the client by making them translate the value in your product or service, you are spelling it out for them. This clarifies the process and puts you one step closer to a “yes”. The FAB takes what your product and ties it into PPI – Productivity, Profitability and Image. Source
So, FAB is just a clever sales technique. Since it’s used by the Big Pharma peddlers too and since they apparently also neglect mentioning any detrimental side-effects to potential customers, it goes to show that indeed sales quota are more important than customer welfare.
- From Wikipedia:
Selective serotonin reuptake inhibitors or serotonin-specific reuptake inhibitor[1] (SSRIs) are a class of compounds typically used as antidepressants in the treatment of depression, anxiety disorders, and some personality disorders. They are also typically effective and used in treating premature ejaculation problems as well as some cases of insomnia.
SSRIs increase the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor. They have varying degrees of selectivity for the other monoamine transporters, with pure SSRIs having only weak affinity for the noradrenaline and dopamine transporter.
The first class of psychotropic drugs to be rationally designed, SSRIs are the most widely prescribed antidepressants in many countries.[2]
[…]
Medical indications
The main indication for SSRIs is clinical depression. SSRIs are frequently prescribed for anxiety disorders like social anxiety, panic disorders, obsessive-compulsive disorder (OCD), eating disorders, chronic pain, and occasionally for Posttraumatic stress disorder (PTSD). Though not specifically indicated by the manufacturers, they are sometimes prescribed to treat irritable bowel syndrome (IBS), Lichen simplex chronicus, and premature ejaculation.All SSRIs are approved in the US for use with psychiatric disorders as outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV).
The uses for which SSRIs are approved vary by country and is determined by the overseeing medical branch of government in charge of regulating drugs. In the United States, the Food and Drug Administration (FDA) makes these approvals after trials have been submitted by pharmaceutical companies. In Europe, drugs can be approved either by the European Medicines Agency for human consumption throughout the European Union or by the regulatory agencies of individual countries for use within those countries.[citation needed]. In Canada the drug approval process is carried out by Health Canada. Source
-
A sample of those who have been on the Eli Lilly payroll includes:
- Former President George Herbert Walker Bush (one-time member of the Eli Lilly board of directors)
- Former CEO of Enron, Ken Lay (one-time member of the Eli Lilly board of directors)
- George W. Bush’s former director of Management and Budget, Mitch Daniels (a former Eli Lilly vice president)
- George W. Bush’s Homeland Security Advisory Council member, Sidney Taurel (current CEO of Eli Lilly)
- The National Alliance for the Mentally Ill (a recipient of Eli Lilly funding)
[…]
In 2002, Eli Lilly flexed its muscles at the highest level of the U.S. government in an audacious Lillygate. The event was the signing of the Homeland Security Act, praised by President George W. Bush as a “heroic action” that demonstrated “the resolve of this great nation to defend our freedom, our security and our way of life.” Soon after the Act was signed, New York Times columnist Bob Herbert discovered what had been slipped into the Act at the last minute and on November 25, 2002, he wrote, “Buried in this massive bill, snuck into it in the dark of night by persons unknown…was a provision that—incredibly—will protect Eli Lilly and a few other big pharmaceutical outfits from lawsuits by parents who believe their children were harmed by thimerosal.”Thimerosal is a preservative that contains mercury and is used by Eli Lilly and others in vaccines. In 1999 the American Academy of Pediatrics and the Public Health Service urged vaccine makers to stop using mercury-based preservatives. In 2001 the Institute of Medicine concluded that the link between autism and thimerosal was “biologically plausible.” By 2002, thim- erosal lawsuits against Eli Lilly were progressing through the courts. The punchline of this Lillygate is that, in June 2002, President George W. Bush had appointed Eli Lilly’s CEO, Sidney Taurel, to a seat on his Homeland Security Advisory Council. Ultimately, even some Republican senators became embarrassed by this Lillygate and, by early 2003, moderate Republicans and Democrats agreed to repeal this particular provision in the Homeland Security Act.
[…]
Looking back further to 1992, Alexander Cockburn, in both the Nation and the New Statesman, was one of the first to connect the dots between the Bush family and Eli Lilly. After George Herbert Walker Bush left his CIA director post in 1977 and before becoming vice president under Ronald Reagan in 1980, he was on Eli Lilly’s board of directors. As vice president, Bush failed to disclose his Lilly stock and lobbied hard on behalf of Big Pharma—especially Eli Lilly. For example, Bush sought special tax breaks from the IRS for Lilly and other pharmaceutical corporations that were manufacturing in Puerto Rico.Cockburn also reported on Mitch Daniels, then a vice president at Eli Lilly, who in 1991 co-chaired a fundraiser that collected $600,000 for the Bush-Quayle campaign. This is the same Mitch Daniels who in 2001 became George W. Bush’s Director of Management and Budget. In June 2003, soon after Daniels departed from that job, he ran for governor of Indiana (home to Eli Lilly headquarters). In a piece in the Washington Post called “Delusional on the Deficit,” Senator Ernest Hollings wrote, “When Daniels left two weeks ago to run for governor of Indiana, he told the Post that the government is ‘fiscally in fine shape.’ Good grief! During his 29-month tenure, he turned a so-called $5.6 trillion, 10-year budget surplus into a $4 trillion deficit—a mere $10 trillion downswing in just two years. If this is good fiscal policy, thank heavens Daniels is gone.” Source
- See under section Eli Lilly and the Bush Family at Wikipedia.
A Phil-for-an-ill Blog 